• +353-1-415-1241(GMT OFFICE HOURS)
  • 1-800-526-8630(US/CAN TOLL FREE)
  • 1-917-300-0470(EST OFFICE HOURS)

PRODUCT FILTERS

REGION

606
23
13
13
12

COUNTRY

12
7
4
3
2

PRICE

537
587
612
869

PUBLISHED

6
30
123
869

PRODUCT TYPE

486
382
1

Immune Disorders

More than 150 primary immunodeficiency diseases (PIDs) have been identified, a number that does not include acquired immunodeficiencies. Examples of immune disorders include Type 1 diabetes, rheumatoid arthritis, allergies, Crohn’s Disease, and HIV, which infects over 0.5% of the world’s population.

In the reports and subscriptions listed under Research and Markets’ category you will find pipeline assessments of drugs and therapeutics, market forecasts, investment and growth opportunities, and much more. Also explored in-depth is the key role of immune response and pharmaceuticals in transplant medicine, with reviews of clinical trials, market trends and major companies in the areas of lung transplants, liver transplants, transplant inflammation/rejection, etc.

Key players profiled include Abbott Laboratories, Pfizer, Johnson & Johnson, Biogen Idec, Amgen, Bayer AG, Sanofi, and more. Show Less
Read more

PRODUCT TITLE

Inflammation - Pipeline Review, H1 2013

Inflammation – Pipeline Review, H1 2013 Summary 'Inflammation - Pipeline Review, H1 2013', provides an overview of the indication's therapeutic pipeline This report provides information on the therapeutic...

June 2013
FROM

Transplantation Global Clinical Trials Review, H1, 2013

Transplantation Global Clinical Trials Review, H1, 2013 Summary Our clinical trial report, “Transplantation Global Clinical Trials Review, H1, 2013" provides data on the Transplantation clinical trial...

June 2013
FROM
Triple Analysis: Melanoma, Apoptosis and Peptides Triple Analysis: Melanoma, Apoptosis and Peptides - Product Thumbnail Image

Triple Analysis: Melanoma, Apoptosis and Peptides

This triple analysis focuses on cancer drug development strategies in one specific cancer indication (Melanoma), one mechanism/target/effect area (Apoptosis) and one compound specific area (Peptides)....

June 2013
FROM
Triple Analysis: Melanoma, Apoptosis and Protein Kinase Inhibitors Triple Analysis: Melanoma, Apoptosis and Protein Kinase Inhibitors - Product Thumbnail Image

Triple Analysis: Melanoma, Apoptosis and Protein Kinase Inhibitors

This triple analysis focuses on cancer drug development strategies in Melanoma and by the two mechanism/target/effect areas of Apoptosis and Protein Kinase Inhibitors. Each of these three individual...

June 2013
FROM
Triple Analysis: Melanoma, Apoptosis and Antibodies Triple Analysis: Melanoma, Apoptosis and Antibodies - Product Thumbnail Image

Triple Analysis: Melanoma, Apoptosis and Antibodies

This triple analysis focuses on cancer drug development strategies in one specific cancer indication (Melanoma), one mechanism/target/effect area (Apoptosis) and one compound specific area (Antibodies)....

June 2013
FROM
Triple Analysis: Melanoma, Apoptosis and Angiogenesis Triple Analysis: Melanoma, Apoptosis and Angiogenesis - Product Thumbnail Image

Triple Analysis: Melanoma, Apoptosis and Angiogenesis

This triple analysis focuses on cancer drug development strategies in Melanoma and by the two mechanism/target/effect areas of Apoptosis and Angiogenesis. Each of these three individual parts is evaluated...

June 2013
FROM
Triple Analysis: Melanoma, Pancreatic Cancer and Apoptosis Triple Analysis: Melanoma, Pancreatic Cancer and Apoptosis - Product Thumbnail Image

Triple Analysis: Melanoma, Pancreatic Cancer and Apoptosis

This triple analysis focuses on cancer drug development strategies in both Melanoma and Pancreatic Cancer and by the mechanism/target/effect of Apoptosis. Each of these three individual parts is evaluated...

June 2013
FROM
Triple Analysis: Lymphoma, Melanoma and Apoptosis Triple Analysis: Lymphoma, Melanoma and Apoptosis - Product Thumbnail Image

Triple Analysis: Lymphoma, Melanoma and Apoptosis

This triple analysis focuses on cancer drug development strategies in both Lymphoma and Melanoma and by the mechanism/target/effect of Apoptosis. Each of these three individual parts is evaluated according...

June 2013
FROM
Triple Analysis: Lung Cancer, Melanoma and Apoptosis Triple Analysis: Lung Cancer, Melanoma and Apoptosis - Product Thumbnail Image

Triple Analysis: Lung Cancer, Melanoma and Apoptosis

This triple analysis focuses on cancer drug development strategies in both Lung Cancer and Melanoma and by the mechanism/target/effect of Apoptosis. Each of these three individual parts is evaluated...

June 2013
FROM
Triple Analysis: Colorectal Cancer, Melanoma and Apoptosis Triple Analysis: Colorectal Cancer, Melanoma and Apoptosis - Product Thumbnail Image

Triple Analysis: Colorectal Cancer, Melanoma and Apoptosis

This triple analysis focuses on cancer drug development strategies in both Colorectal Cancer and Melanoma and by the mechanism/target/effect of Apoptosis. Each of these three individual parts is evaluated...

June 2013
FROM

Enterovirus Infections - Pipeline Review, H1 2013

Enterovirus Infections – Pipeline Review, H1 2013 Summary Global Markets Direct’s, 'Enterovirus Infections - Pipeline Review, H1 2013', provides an overview of the indication’s therapeutic pipeline....

May 2013
FROM

Heart Transplantation - Pipeline Review, H1 2013

Heart Transplantation – Pipeline Review, H1 2013 Summary Global Markets Direct’s, 'Heart Transplantation - Pipeline Review, H1 2013', provides an overview of the indication’s therapeutic pipeline....

May 2013
FROM

Ischemic Cardiomyopathy - Pipeline Review, H1 2013

Ischemic Cardiomyopathy – Pipeline Review, H1 2013 Summary Global Markets Direct’s, 'Ischemic Cardiomyopathy - Pipeline Review, H1 2013', provides an overview of the indication’s therapeutic pipeline....

May 2013
FROM

Sarcoidosis - Pipeline Review, H1 2013

Sarcoidosis – Pipeline Review, H1 2013 Summary Global Markets Direct’s, 'Sarcoidosis - Pipeline Review, H1 2013', provides an overview of the indication’s therapeutic pipeline. This report provides...

May 2013
FROM

Skin And Skin Structure Infections (SSSI) Caused By Bacteria - Pipeline Review, H1 2013

Skin And Skin Structure Infections (SSSI) Caused By Bacteria – Pipeline Review, H1 2013 Summary Global Markets Direct’s, 'Skin And Skin Structure Infections (SSSI) Caused By Bacteria - Pipeline Review,...

May 2013
FROM

Chronic Inflammation - Pipeline Review, H1 2013

Chronic Inflammation – Pipeline Review, H1 2013 Summary Global Markets Direct’s, 'Chronic Inflammation - Pipeline Review, H1 2013', provides an overview of the indication’s therapeutic pipeline. This...

May 2013
FROM

Grass Pollen Allergy - Pipeline Review, H1 2013

Grass Pollen Allergy – Pipeline Review, H1 2013 Summary Global Markets Direct’s, 'Grass Pollen Allergy - Pipeline Review, H1 2013', provides an overview of the indication’s therapeutic pipeline. This...

May 2013
FROM

Diabetic Complications - Pipeline Review, H1 2013

Diabetic Complications – Pipeline Review, H1 2013 Summary Global Markets Direct’s, 'Diabetic Complications - Pipeline Review, H1 2013', provides an overview of the indication’s therapeutic pipeline....

May 2013
FROM

Warts - Pipeline Review, H1 2013

Warts – Pipeline Review, H1 2013 Summary Global Markets Direct’s, 'Warts - Pipeline Review, H1 2013', provides an overview of the indication’s therapeutic pipeline. This report provides information...

May 2013
FROM

Wrinkles - Pipeline Review, H1 2013

Wrinkles – Pipeline Review, H1 2013 Summary Global Markets Direct’s, 'Wrinkles - Pipeline Review, H1 2013', provides an overview of the indication’s therapeutic pipeline. This report provides information...

May 2013
FROM
Loading Indicator

Our Clients

Our clients' logos